• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of heparin-based nanoparticles with multi-functional biological properties intended for rheumatoid arthritis therapy

Research Project

Project/Area Number 23659022
Research Category

Grant-in-Aid for Challenging Exploratory Research

Allocation TypeMulti-year Fund
Research Field Physical pharmacy
Research InstitutionKyoto University

Principal Investigator

YAMASHITA Fumiyoshi  京都大学, 大学院・薬学研究科, 准教授 (30243041)

Co-Investigator(Kenkyū-buntansha) HASHIDA Yasuhiko  京都大学, 物質-細胞統合システム拠点, 特定研究員 (30512462)
Co-Investigator(Renkei-kenkyūsha) HIGUCHI Yuriko  京都大学, 大学院・薬学研究科, 助教 (40402797)
Project Period (FY) 2011 – 2012
Project Status Completed (Fiscal Year 2012)
Budget Amount *help
¥3,770,000 (Direct Cost: ¥2,900,000、Indirect Cost: ¥870,000)
Fiscal Year 2012: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2011: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
Keywordsドラッグデリバリー / ヘパリンナノ粒子 / 関節リウマチ / マクロファージ / 炎症性サイトカイン / TLR-4
Research Abstract

This study aimed to develop a nano-sized drug carrier consisting of heparin, which has a variety of biological functions, and apply it to rheumatoid arthritis therapy. First, we conjugated native heparin or partially ring-opened heparin with sphingosine. These sphingosine-heparin conjugates form a self-assembling nanoparticle in water, which has the diameter of 120-200 nm and the ζpotential of -50 to -60 mV. Although inflammatory cytokines were produced following stimulation of mouse peritoneal macrophages with lipopolysaccharides, co-presence of the sphingosine-heparin conjugates, even without any drugs, significantly reduced the cytokine production. On the other hand, sphingosine-heparin conjugates were not effective against poly I:poly C-induced TNF-α production, suggesting that the conjugates act selectively on the TLR4/NF-κB pathway. In the mouse model of type II collagen-induced arthritis, the sphingosine-heparin conjugates, especially that derived from partially ring-opened heparin, showed remarkable anti-inflammatory effects.

Report

(3 results)
  • 2012 Annual Research Report   Final Research Report ( PDF )
  • 2011 Research-status Report
  • Research Products

    (7 results)

All 2013 2012 Other

All Presentation (6 results) Remarks (1 results)

  • [Presentation] Mechanisms of anti-inflammatory effect of heparin-sphingosine nanoparticles in activated macrophages in vitro2013

    • Author(s)
      Hasan Babazada、 福岡美帆、 山下富義、橋田 充
    • Organizer
      日本薬学会第133 年会
    • Place of Presentation
      パシフィコ横浜(神奈川県)
    • Related Report
      2012 Final Research Report
  • [Presentation] スフィンゴシン結合両親媒性ヘパリンによるナノ粒子の調整と物性評価2013

    • Author(s)
      福岡美帆、 Hasan Babazada、山下富義、橋田 充
    • Organizer
      日本薬学会第133 年会
    • Place of Presentation
      パシフィコ横浜(神奈川県)
    • Related Report
      2012 Final Research Report
  • [Presentation] Mechanisms of anti-inflammatory effect of heparin-sphingosine nanoparticles in activated macrophages in vitro2013

    • Author(s)
      Hasan Babazada、福岡美帆、山下富義、橋田 充
    • Organizer
      日本薬学会第133年会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Related Report
      2012 Annual Research Report
  • [Presentation] スフィンゴシン結合両親媒性ヘパリンによるナノ粒子の調整と物性評価2013

    • Author(s)
      福岡美帆、Hasan Babazada、山下富義、橋田 充
    • Organizer
      日本薬学会第133年会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Related Report
      2012 Annual Research Report
  • [Presentation] ヘパリンナノパーティクルの物性及び免疫抑制効果の検討2012

    • Author(s)
      Hasan Babazada、福岡美帆、 山下富義、橋田 充
    • Organizer
      日本薬物動態学会第27 年会
    • Place of Presentation
      タワーホール船堀(東京都)
    • Related Report
      2012 Final Research Report
  • [Presentation] Immunosuppressive effect of heparin nanoparticles on activated macrophages in primary culture2012

    • Author(s)
      Hasan Babazada, Miho Fukuoka, Fumiyoshi Yamashita, Mitsuru Hashida
    • Organizer
      第27回日本薬物動態学会年会
    • Place of Presentation
      タワーホール船堀(東京)
    • Related Report
      2012 Annual Research Report
  • [Remarks]

    • URL

      http://dds.pharm.kyoto-u.ac.jp/report/yamashita/kaken/houga2011.html

    • Related Report
      2012 Final Research Report

URL: 

Published: 2011-08-05   Modified: 2019-07-29  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi